protein

Recombinant Canine CCL4/MIP-1 beta Protein, CF

5839-MB-025/CF

25 ug

432 USD

5839-MB-025/CF

Recombinant Canine CCL4/MIP-1 beta Protein, CF

25 ug

The Recombinant Canine CCL4/MIP-1 beta Protein, CF from R&D Systems is derived from E. coli. The Recombinant Canine CCL4/MIP-1 beta Protein, CF has been validated for the following applications: Bioactivity.

CCL4/MIP-1 beta

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in PBS.

Unconjugated

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain

Canine

11 kDa, reducing conditions

7.8 kDa

CCL4

Measured by its ability to chemoattract BaF3 mouse pro-B cells transfected with human CCR5. The ED50 for this effect is 0.75-3.5 ng/mL

<0.10 EU per 1 ╡g of the protein by the LAL method.

NP_001005250

Bioactivity

E. coli -derived canine CCL4/MIP-1 beta protein Ala24-Asn92

E. coli

432 USD

ACT2, ACT-2, AT744.1, C-C motif chemokine 4, chemokine (C-C motif) ligand 4, Exodus-3, G-26, G-26 T-lymphocyte-secreted protein, HC21, LAG1, LAG-1, Lymphocyte activation gene 1 protein, Macrophage inflammatory protein 1-beta, MIP1 beta, MIP-1 beta, MIP1B, MIP1B1, MIP-1-beta, MIP-1-beta(1-69), PAT 744, Protein H400, SCYA2, SCYA4, secreted protein G-26, SIS-gamma, small inducible cytokine A4 (homologous to mouse Mip-1b), Small-inducible cytokine A4, T-cell activation protein 2

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.